GFN 2014

The following videos are part of the record of the first Global Forum on Nicotine, held in Warsaw, Poland, on June 27 & 28 2014. The event was organized by Knowledge Action Change and more from the conference archive can be found at gfn.net.co/2014 Special thanks to Jon Derricott for his work in filming the event.

For details about next year’s Global Forum on Nicotine, taking place again in Warsaw, on June 5 & 6 2015, please visit gfn.net.co/2015

Professor Peter Hajek

Professor Peter Hajek The Michael Russel Orientation – Nicotine Science and public health

Prof Peter Hajek , Queen Mary University, London, United Kingdom
Watch Video   Peter Hajek is Professor of Clinical Psychology, Head of Psychology and Director of the Tobacco Dependence Research Unit at the Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine and Dentistry, Queen Mary University of London. His research is concerned primarily with understanding health behaviours, and developing and evaluating both behavioural and pharmacological treatments for dependent smokers and for people with weight problems. He has contributed to the establishment of the UK specialist stop-smoking service, training of its staff, and relevant NICE guidelines. He authored or co-authored over 280 publications on psychological treatments and on smoking cessation.
Karl Fagerström

Karl Fagerström Nicotine – relative addictiveness of different products

Dr. Karl Fagerström, Smokers Information Center, Sweden
Watch Video   Karl is a licensed clinical psychologist with a Ph.D. on nicotine dependence and smoking cessation, who started a smoking cessation clinic in 1975 and invented the Fagerstrom Test for Cigarette Dependence. In the 70s and 80s he served as the editor – in – chief for the Scandinavian Journal for Behaviour Therapy. Currently he works with his own private consultancy (Fagerstrom Consulting). He is a founding member of the Society for Research on Nicotine and Tobacco and currently a Deputy Editor of the Nicotine & Tobacco Research. He started the European SRNT affiliate in 1999. His main research contributions have been in the fields of Behaviour Medicine, Tobacco and Nicotine with over 160 peer reviewed publications of which he is the first author of 95. The current main interest is on reducing harm and exposure to tobacco toxins. He was awarded the WHO medal 1999 for outstanding work in tobacco control and is the recipient of the 2013 Award on Clinical Science from the Society for Research on Tobacco and Nicotine.
Riccardo Polosa, MD.

Riccardo Polosa, MD. Harmful and potentially harmful constituents in E-Cigarettes and nicotine liquids

Prof Riccardo Polosa, Prof Riccardo Polosa , University of Catania, Italy
Watch Video   Dr. Polosa is Director of the Institute for Internal and Emergency Medicine of the University of Catania in Italy. He is also in charge of the University’s Centre for Tobacco Research (CPCT), and Honorary Professor of Medicine at Southampton University (UK). He is author of more than 250 peer reviewed articles and books mainly covering respiratory medicine, clinical immunology, and tobacco addiction. On top of his academic work, he serves also as chief scientific advisor for Lega Italiana Anti Fumo (LIAF), the Italian Anti-Smoking League. Prof Polosa’s and his research team have lead several clinical trials on e-cigarettes.
Konstantinos Farsalinos, MD.

Konstantinos Farsalinos, MD. Gaps in the nicotine science agenda

Dr. Konstantinos Farsalinos , Onassis Cardiac Surgery Center, Athens, Greece
Watch Video   Dr. Konstantinos Farsalinos is a cardiologist, working as researcher at Onassis Cardiac Surgery Center in Athens-Greece and at Medical Imaging Research Center, University Hospital Gathuisberg in Leuven-Belgium. His main research interests are new modalities in cardiovascular imaging and he has received a scholarship from the Greek Society of Cardiology for research and education in this field. He has studied the effects of smoking on subclinical cardiac dysfunction using new imaging techniques since 2010. He has been actively performing research on electronic cigarettes since 2011 as a principle investigator, in both clinical and laboratory level. Examples of his work include the first study on the cytotoxic effects of electronic cigarette vapor on cultured cells and the immediate effects of electronic cigarettes used on cardiac function and coronary circulation. He has presented his research in major international scientific congresses and has published more than 15 studies and letters about e-cigarettes in peer-reviewed medical journals.
JACQUES LE HOUEZEC, Ph.D.

JACQUES LE HOUEZEC, Ph.D. Electronic Cigarettes in Europe: A Consumer Led Public Health Revolution

Dr. Jacques le Houezec , Charter Member of SNRT, UK Centre for Tobacco Control Studies, University of Nottingham in England, Consultant, France
Watch Video   Trained neuroscientist in Paris (Ph.D. in 1988) who spent 2 years as a post-doctoral fellow in Clinical Pharmacology & Experimental Therapeutics at the University of California. After 6 years of research in La Salpêtrière Hospital (Paris), and teaching at Paris V and Paris VII Universities, he became a freelance consultant for the pharmaceutical industry and the public sector (training smoking cessation specialists, and writing monthly scientific digests for them). He is a Charter Member of SRNT and was part of the core group who founded SRNT Europe. He participated in the Steering Committee of the WHO Europe Partnership Project to reduce Tobacco Dependence (1991-2001), and was also on the European Commission’s Scientific Committee on Emerging and Newly Identified Health Risks (SCHENIR) expert group on smokeless tobacco (2006-2008). He is also Honorary Lecturer, UK Centre for Tobacco Control Studies, University of Nottingham, England, and manager of www.treatobacco.net the SRNT & SSA website dedicated to tobacco dependence treatment.
Deborah Arnott

Deborah Arnott The tobacco harm reduction policy environment and context

Deborah Arnott, ASH UK (representing the Framework Convention Alliance)
Watch Video   Deborah Arnott is Chief Executive of Action on Smoking and Health (UK), honorary associate professor in the Division of Epidemiology and Public Health at the University of Nottingham, honorary fellow of the Royal College of Physicians and member of the RCP’s Tobacco Advisory Group. A recognized international expert on tobacco control and the WHO Framework Convention on Tobacco Control, she has a particular interest in nicotine regulation and harm reduction. She was a member of the NICE committee which developed the guidance on Tobacco Harm Reduction and of the Commission on Human Medicines expert advisory group to the MHRA on nicotine containing products, as well as being a civil society observer to the WHO FCTC Article 9 and 10 working group on tobacco product regulation. Previously Head of Consumer Education for the UK’s statutory financial services regulator the FSA, she also has experience as a journalist in print and television.
Lynne Dawkins

Lynne Dawkins Nicotine delivery and sensorimotor aspects of vaping

Dr. Lynne Dawkins, School of Psychology, University of East London, United Kingdom
Watch Video   Lynne Dawkins is an experimental psychologist and leader of the Drugs and Addictive Behaviours Research Group at UEL. She has over 15 years’ experience of working with smokers in research contexts and, more recently, with novice and experienced e-cigarette users. Dr. Dawkins is one of the UK’s leading authorities on e-cigarettes having published papers on their utilization, effects, and nicotine delivery. She has disseminated her findings widely via academic conference, public lectures and online media.
Linda Bauld

Linda Bauld Using evidence to negotiate new policies on tobacco harm reduction

Prof Linda Bauld, University of Stirling and UK Centre for Tobacco and Alcohol Studies, UK
Watch Video   Linda Bauld is Professor of Health Policy at the University of Stirling, Director of the Institute for Social Marketing and Deputy Director of the UK Centre for Tobacco and Alcohol Studies. She has a background in applied policy research and for the past 15 years her research interests have centered on the evaluation of public health interventions. She has conducted studies on drug and alcohol use, inequalities in health and, most notably, on tobacco control and smoking cessation. She is a former scientific adviser on tobacco control to the UK government and currently chairs a number of public health advisory and funding committees for NICE, Cancer Research UK and the Scottish government.

© 2014 E-Research Foundation. All Rights Reserved.